Director/PDMR Shareholding

RNS Number : 1765M

Provexis PLC

12 September 2019

 

12 September 2019

Provexis plc

("Provexis" or the "Company")

Director / PDMR notification

Provexis, the business that develops, licenses and sells the proprietary, scientifically-proven Fruitflow® heart-health functional food ingredient, announces that Ian Ford, CEO and CFO, purchased a total of 5,000,000 ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") on 12 September 2019 at an average price of 0.338 pence per Ordinary Share.

Following this purchase, Mr Ford has a total beneficial interest in 10,000,000 Ordinary Shares, equivalent to 0.50% of the Company's issued share capital.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them are set out below pursuant to the EU Market Abuse regulation.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Ian Ford (Director and PDMR) - shares acquired on behalf of Mr Ford's children (under the age of 18) who are persons closely associated with Mr Ford
2	Reason for the notification
a)	Position/status	See 1a) above
b)	Initial notification / Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	PROVEXIS PLC
b)	LEI	21380042E3Y3N9VZ6N48
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 0.1p each ISIN: GB00B0923P27
b)	Nature of the transaction	Purchase of ordinary shares
c)	Price(s) and volume(s)	Price(s) Volume(s) 0.33 pence and 0.345 pence 2,500,000 2,500,000
d)	Aggregated information - Aggregated volume - Price	5,000,000 shares Average price of 0.338 pence per share
e)	Date of the transaction	12 September 2019
f)	Place of the transaction	London Stock Exchange, AIM Market

For further information please contact:

Provexis plc Dawson Buck, Chairman Ian Ford, CEO & CFO	Tel:         [phone]                 [e-mail]
Allenby Capital Limited Nick Naylor / Liz Kirchner	Tel:         [phone]

Notes for editors

About Provexis plc

AIM-listed Provexis is focused on the development, licensing and sales of its proprietary, scientifically-proven Fruitflow® heart-health functional food ingredient.

Provexis was founded in 1999 and is headquartered in Reading, Berkshire.

Provexis shares are traded on the AIM market of the London Stock Exchange under the ticker symbol PXS.

For further information, please visit www.provexis.com and www.fruitflowplus.com.

 

END

 

 

DSHGGUQGBUPBGCP